The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Cancer Immunotherapy by Dendritic Cells
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 3×
“HMGB1 protein reportedly binds to TLR2 and TLR4 (Park et al., 2006), consistent with immune activation by dying tumor cells involving both HMGB1 and TLR4 (Apetoh et al., 2007).”
BackgroundRecognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
Self-citationGrulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,092
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1806 · Cited by 2,085
Immunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A., & Dudley, M. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2355 · Cited by 1,659
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575 · cited 11×
“In addition, many tumors overexpress STAT3 protein, in turn causing STAT3 expression in tumor-infiltrating leukocytes, associated with production of TGF-b and IL-10 and suppression of Th1 cell responses.”
BackgroundInfluentialAdaptive immunity maintains occult cancer in an equilibrium state
Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., & Schreiber, R. D. (2007) · Nature · doi:10.1038/nature06309 · Cited by 1,436
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314
Altered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
Albert, M. L., Pearce, S. F. A., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., & Bhardwaj, N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1359 · Cited by 1,234
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
Steinman, R. M., & Nussenzweig, M. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231606698 · Cited by 1,166
Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., & Lanzavecchia, A. (2005) · Nature Immunology · doi:10.1038/ni1223 · Cited by 1,157
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Self-citationInhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mulé, J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,031
Mechanisms and functional significance of tumour-induced dendritic-cell defects
Gabrilovich, D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1498 · Cited by 1,024
Sutmuller, R. P. M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N. M., Wildenberg, M. E., Allison, J. P., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.823 · Cited by 1,008
Self-citationKool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Dendritic cell immunotherapy: mapping the way
Figdor, C. G., de Vries, I. J. M., Lesterhuis, W. J., & Melief, C. J. M. (2004) · Nature Medicine · doi:10.1038/nm1039 · Cited by 945
Self-citationHigh mobility group box 1 protein interacts with multiple Toll-like receptors
Park, J. S., Gamboni-Robertson, F., He, Q., Svetkauskaite, D., Kim, J.-Y., Strassheim, D., Sohn, J.-W., Yamada, S., Maruyama, I., Banerjee, A., et al. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00401.2005 · Cited by 932
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., & Tough, D. F. (2003) · Nature Immunology · doi:10.1038/ni978 · Cited by 818
Sharma, M. D., Baban, B., Chandler, P., Hou, D.-Y., Singh, N., Yagita, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 792
Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., & Zitvogel, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050463 · Cited by 776
Finn, O. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072739 · Cited by 774
Allan, R. S., Waithman, J., Bedoui, S., Jones, C. M., Villadangos, J. A., Zhan, Y., Lew, A. M., Shortman, K., Heath, W. R., & Carbone, F. R. (2006) · Immunity · doi:10.1016/j.immuni.2006.04.017 · Cited by 757
Cross‐presentation, dendritic cell subsets, and the generation of immunity to cellular antigens
Heath, W. R., Belz, G. T., Behrens, G. M. N., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M., Wilson, N. S., Carbone, F. R., & Villadangos, J. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00142.x · Cited by 735
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
Bachmaier, K., Krawczyk, C., Kozieradzki, I., Kong, Y.-Y., Sasaki, T., Oliveira-dos-Santos, A., Mariathasan, S., Bouchard, D., Wakeham, A., Itie, A., et al. (2000) · Nature · doi:10.1038/35003228 · Cited by 666
Hodi, F. S., Butler, M., Oble, D. A., Seiden, M. V., Haluska, F. G., Kruse, A., MacRae, S., Nelson, M., Canning, C., Lowy, I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712237105 · Cited by 650
The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo
Iyoda, T., Shimoyama, S., Liu, K., Omatsu, Y., Akiyama, Y., Maeda, Y., Takahara, K., Steinman, R. M., & Inaba, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020161 · Cited by 648
Cbl-b regulates the CD28 dependence of T-cell activation
Chiang, Y. J., Kole, H. K., Brown, K., Naramura, M., Fukuhara, S., Hu, R.-J., Jang, I. K., Gutkind, J. S., Shevach, E., & Gu, H. (2000) · Nature · doi:10.1038/35003235 · Cited by 621
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P., & Bronte, V. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00602.x · Cited by 608
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
Melief, C. J. M., & van der Burg, S. H. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2373 · Cited by 594
Self-citationThe inflammatory chemokines CCL2 and CCL5 in breast cancer
Soria, G., & Ben-Baruch, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.018 · Cited by 593
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Hamzah, J., Jugold, M., Kiessling, F., Rigby, P., Manzur, M., Marti, H. H., Rabie, T., Kaden, S., Gröne, H.-J., Hämmerling, G. J., et al. (2008) · Nature · doi:10.1038/nature06868 · Cited by 564
Blaskovich, M. A., Sun, J., Cantor, A. B., Turkson, J., Jove, R., & Sebti, S. M. (2003) · PubMed · Cited by 561
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
Sancho, D., Mourão-Sá, D., Joffre, O. P., Schulz, O., Rogers, N. C., Pennington, D. J., Carlyle, J. R., & Reis e Sousa, C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34584 · Cited by 519
GeurtsvanKessel, C. H., Willart, M. A. M., van Rijt, L. S., Muskens, F., Kool, M., Baas, C., Thielemans, K., Bennett, C., Clausen, B. E., Hoogsteden, H. C., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071365 · Cited by 480
Nowak, A. K., Lake, R. A., Marzo, A. L., Scott, B., Heath, W. R., Collins, E. J., Frelinger, J. A., & Robinson, B. W. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4905 · Cited by 463
Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity
Smith, C. M., Wilson, N. S., Waithman, J., Villadangos, J. A., Carbone, F. R., Heath, W. R., & Belz, G. T. (2004) · Nature Immunology · doi:10.1038/ni1129 · Cited by 448
Steinman, R. M. (2002) · Medical Entomology and Zoology · Cited by 446
Cross-presentation by intercellular peptide transfer through gap junctions
Neijssen, J., Herberts, C., Drijfhout, J. W., Reits, E., Janssen, L., & Neefjes, J. (2005) · Nature · doi:10.1038/nature03290 · Cited by 445
Sanderson, K., Scotland, R., Lee, P., Liu, D., Groshen, S., Snively, J., Sian, S., Nichol, G., Davis, T., Keler, T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.128 · Cited by 434
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.
Nowak, A. K., Robinson, B. W. S., & Lake, R. (2003) · PubMed · Cited by 421
Zwaveling, S., Mota, S. C. F., Nouta, J., Johnson, M., Lipford, G. B., Offringa, R., van der Burg, S. H., & Melief, C. J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.350 · Cited by 417
Self-citationOX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
Piconese, S., Valzasina, B., & Colombo, M. P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071341 · Cited by 405
Nees, M., Geoghegan, J. M., Hyman, T., Frank, S., Miller, L., & Woodworth, C. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4283-4296.2001 · Cited by 387
The dominant role of CD8+dendritic cells in cross-presentation is not dictated by antigen capture
Schnorrer, P., Behrens, G. M. N., Wilson, N. S., Pooley, J. L., Smith, C. M., El-Sukkari, D., Davey, G., Kupresanin, F., Li, M., Maraskovsky, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601956103 · Cited by 383
Hasan, U. A., Bates, E., Takeshita, F., Biliato, A., Accardi, R., Bouvard, V., Mansour, M., Vincent, I., Gissmann, L., Iftner, T., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3186 · Cited by 380
Welters, M. J. P., Kenter, G. G., Piersma, S. J., Vloon, A. P. G., Löwik, M. J. G., Berends-van der Meer, D. M. A., Drijfhout, J. W., Valentijn, A. R. P. M., Wafelman, A. R., Oostendorp, J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1880 · Cited by 373
Self-citationKalergis, A. M., & Ravetch, J. V. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020338 · Cited by 372
Su, Z., Dannull, J., Yang, B. K., Dahm, P., Coleman, D., Yancey, D., Sichi, S., Niedzwiecki, D., Boczkowski, D., Gilboa, E., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3798 · Cited by 359
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells
Zhang, B., Bowerman, N. A., Salama, J. K., Schmidt, H., Spiotto, M. T., Schietinger, A., Yu, P., Fu, Y.-X., Weichselbaum, R. R., Rowley, D. A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062056 · Cited by 359
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
Muranski, P., Boni, A., Wrzesinski, C., Citrin, D. E., Rosenberg, S. A., Childs, R., & Restifo, N. P. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0666 · Cited by 358
Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction
Jeon, M.-S., Atfield, A., Venuprasad, K., Krawczyk, C., Sarao, R., Elly, C., Yang, C., Arya, S., Bachmaier, K., Su, L., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.013 · Cited by 348
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
Zang, X., & Allison, J. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1030 · Cited by 336
Aspord, C., Pedroza-Gonzalez, A., Gallegos, M., Tindle, S., Burton, E. C., Su, D., Marches, F., Banchereau, J., & Palucka, A. K. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061120 · Cited by 334
Dendritic Cells Acquire Antigens from Live Cells for Cross-Presentation to CTL
Harshyne, L. A., Watkins, S. C., Gambotto, A., & Barratt-Boyes, S. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3717 · Cited by 321
Cancer immunotherapy with mRNA‐transfected dendritic cells
Gilboa, E., & Vieweg, J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00139.x · Cited by 316
Liu, C., Lou, Y., Lizée, G., Qin, H., Liu, S., Rabinovich, B., Kim, G. J., Wang, Y.-H., Ye, Y., Sikora, A. G., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33583 · Cited by 316
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Löwik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Drijfhout, J. W., Wafelman, A. R., Oostendorp, J., Fleuren, G. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1881 · Cited by 315
Self-citationde Jong, A., van Poelgeest, M. I. E., van der Hulst, J. M., Drijfhout, J. W., Fleuren, G. J., Melief, C. J. M., Kenter, G., Offringa, R., & van der Burg, S. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0831 · Cited by 309
Self-citationTumor Escape Mechanism Governed by Myeloid-Derived Suppressor Cells
Nagaraj, S., & Gabrilovich, D. I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6229 · Cited by 305
den Brok, M. H. M. G. M., Sutmuller, R. P. M., Nierkens, S., Bennink, E. J., Frielink, C., Toonen, L. W. J., Boerman, O. C., Figdor, C. G., Ruers, T. J. M., & Adema, G. J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603341 · Cited by 296
CD8 + T Cell Cross-Priming via Transfer of Proteasome Substrates
Norbury, C. C., Basta, S., Donohue, K. B., Tscharke, D. C., Princiotta, M. F., Berglund, P., Gibbs, J., Bennink, J. R., & Yewdell, J. W. (2004) · Science · doi:10.1126/science.1096378 · Cited by 286
Zeelenberg, I. S., Ostrowski, M., Krumeich, S., Bobrie, A., Jancic, C., Boissonnas, A., Delcayre, A., Le Pecq, J.-B., Combadière, B., Amigorena, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3163 · Cited by 286
Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming
Le Bon, A., Durand, V., Kamphuis, E., Thompson, C., Bulfone-Paus, S., Rossmann, C., Kalinke, U., & Tough, D. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4682 · Cited by 283
Tacken, P. J., de Vries, I. J. M., Gijzen, K., Joosten, B., Wu, D., Rother, R. P., Faas, S. J., Punt, C. J. A., Torensma, R., Adema, G. J., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0318 · Cited by 272
Kavanagh, B., O'Brien, S., Lee, D., Hou, Y., Weinberg, V., Rini, B., Allison, J. P., Small, E. J., & Fong, L. (2008) · Blood · doi:10.1182/blood-2007-11-125435 · Cited by 256
Papillomavirus-Like Particles Induce Acute Activation of Dendritic Cells
Lenz, P., Day, P. M., Pang, Y.-Y. S., Frye, S. A., Jensen, P. N., Lowy, D. R., & Schiller, J. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5346 · Cited by 252
Bozzacco, L., Trumpfheller, C., Siegal, F. P., Mehandru, S., Markowitz, M., Carrington, M., Nussenzweig, M. C., Piperno, A. G., & Steinman, R. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610383104 · Cited by 247
CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose
Kurts, C., Sutherland, R. M., Davey, G., Li, M., Lew, A. M., Blanas, E., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12703 · Cited by 245
Schuurhuis, D. H., Ioan-Facsinay, A., Nagelkerken, B., van Schip, J. J., Sedlik, C., Melief, C. J. M., Verbeek, J. S., & Ossendorp, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2240 · Cited by 238
Self-citationImmune complex–mediated antigen presentation induces tumor immunity
Rafiq, K., Bergtold, A., & Clynes, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215640 · Cited by 232
Trumpfheller, C., Finke, J. S., López, C. B., Moran, T. M., Moltedo, B., Soares, H., Huang, Y., Schlesinger, S. J., Park, C. G., Nussenzweig, M. C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052005 · Cited by 231
Bijker, M. S., van den Eeden, S. J. F., Franken, K. L., Melief, C. J. M., van der Burg, S. H., & Offringa, R. (2008) · European Journal of Immunology · doi:10.1002/eji.200737995 · Cited by 229
Self-citationvan Mierlo, G. J. D., den Boer, A. T., Medema, J. P., van der Voort, E. I. H., Fransen, M. F., Offringa, R., Melief, C. J. M., & Toes, R. E. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082107699 · Cited by 222
Self-citationSchulz, O., & Reis e Sousa, C. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01513.x · Cited by 214
Role of Stat3 in suppressing anti-tumor immunity
Kortylewski, M., & Yu, H. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.010 · Cited by 196
Schiavoni, G., Mattei, F., Di Pucchio, T., Santini, S. M., Bracci, L., Belardelli, F., & Proietti, E. (2000) · Blood · doi:10.1182/blood.v95.6.2024 · Cited by 196
Taming cancer by inducing immunity via dendritic cells
Palucka, A. K., Ueno, H., Fay, J. W., & Banchereau, J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00575.x · Cited by 189
Daud, A. I., Mirza, N., Lenox, B., Andrews, S., Urbas, P., Gao, G. X., Lee, J.-H., Sondak, V. K., Riker, A. I., DeConti, R. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9048 · Cited by 184
Melief, C. J. M. (2003) · European Journal of Immunology · doi:10.1002/eji.200324341 · Cited by 181
Self-citationA rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression
Bins, A. D., Jorritsma, A., Wolkers, M. C., Hung, C.-F., Wu, T.-C., Schumacher, T. N. M., & Haanen, J. B. A. G. (2005) · Nature Medicine · doi:10.1038/nm1264 · Cited by 178
den Brok, M. H. M. G. M., Sutmuller, R. P. M., Nierkens, S., Bennink, E. J., Toonen, L. W. J., Figdor, C. G., Ruers, T. J. M., & Adema, G. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0206 · Cited by 176
Khan, S., Bijker, M. S., Weterings, J. J., Tanke, H. J., Adema, G. J., van Hall, T., Drijfhout, J. W., Melief, C. J. M., Overkleeft, H. S., van der Marel, G. A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701705200 · Cited by 175
Self-citationApoptotic Cells Deliver Processed Antigen to Dendritic Cells for Cross-Presentation
Blachère, N. E., Darnell, R. B., & Albert, M. L. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030185 · Cited by 174
OX40 Agonist Therapy Enhances CD8 Infiltration and Decreases Immune Suppression in the Tumor
Gough, M. J., Ruby, C. E., Redmond, W. L., Dhungel, B., Brown, A., & Weinberg, A. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6484 · Cited by 174
Lin, M. L., Zhan, Y., Proietto, A. I., Prato, S., Wu, L., Heath, W. R., Villadangos, J. A., & Lew, A. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712394105 · Cited by 174
Sandel, M. H., Dadabayev, A. R., Menon, A. G., Morreau, H., Melief, C. J. M., Offringa, R., van der Burg, S. H., Janssen-van Rhijn, C. M., Ensink, N. G., Tollenaar, R. A. E. M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1448 · Cited by 173
Self-citationvan Mierlo, G. J. D., Boonman, Z. F. H. M., Dumortier, H. M. H., den Boer, A. T., Fransen, M. F., Nouta, J., van der Voort, E. I. H., Offringa, R., Toes, R. E. M., & Melief, C. J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6753 · Cited by 171
Self-citationThe cell biology of cross‐presentation and the role of dendritic cell subsets
Lin, M., Zhan, Y., Villadangos, J. A., & Lew, A. M. (2008) · Immunology & Cell Biology · doi:10.1038/icb.2008.3 · Cited by 166
Immune-Potentiating Effects of the Chemotherapeutic Drug Cyclophosphamide
Brode, S., & Cooke, A. (2008) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v28.i2.20 · Cited by 165
Dendritic Cells Cross-Dressed with Peptide MHC Class I Complexes Prime CD8+ T Cells
Dolan, B. P., Gibbs, K. D., & Ostrand‐Rosenberg, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6018 · Cited by 164
Spontaneous tumor rejection by cbl-b –deficient CD8+ T cells
Loeser, S., Loser, K., Bijker, M. S., Rangachari, M., van der Burg, S. H., Wada, T., Beissert, S., Melief, C. J. M., & Penninger, J. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061699 · Cited by 161
Self-citationInteractions of tumor cells with dendritic cells: balancing immunity and tolerance
Dhodapkar, M. V., Dhodapkar, K. M., & Palucka, A. K. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402247 · Cited by 154
Luckashenak, N. A., Schroeder, S., Endt, K., Schmidt, D., Mahnke, K., Bachmann, M., Marconi, P., Deeg, C., & Brocker, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.018 · Cited by 151
Mukhopadhaya, A., Hanafusa, T., Jarchum, I., Chen, Y.-G., Iwai, Y., SERREZE, D. V., Steinman, R. M., Tarbell, K. V., & DiLorenzo, T. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802644105 · Cited by 139
Pro-inflammatory prostaglandins and progression of colorectal cancer
Wang, D., & DuBois, R. N. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.004 · Cited by 130
Uric Acid Promotes Tumor Immune Rejection
Hu, D., Moore, A. M., Thomsen, L. L., & Brindle, K. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1586 · Cited by 130
Tumor Growth Enhances Cross-Presentation Leading to Limited T Cell Activation without Tolerance
Nguyen, L. T., Elford, A. R., Murakami, K., Garza, K. M., Schoenberger, S. P., Odermatt, B., Speiser, D. E., & Ohashi, P. S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010032 · Cited by 128
Cancer and inflammation: A complex relationship
Mantovani, A., & Pierotti, M. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.003 · Cited by 125
Dendritic cell vaccines in melanoma: From promise to proof?
Lesterhuis, W. J., Aarntzen, E. H. J. G., de Vries, I. J. M., Schuurhuis, D. H., Figdor, C. G., Adema, G. J., & Punt, C. J. A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.12.007 · Cited by 124
Willimsky, G., Czéh, M., Loddenkemper, C., Gellermann, J., Schmidt, K., Wust, P., Stein, H., & Blankenstein, T. J. F. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072016 · Cited by 120
Immune Complex-Loaded Dendritic Cells Are Superior to Soluble Immune Complexes as Antitumor Vaccine
Schuurhuis, D. H., van Montfoort, N., Ioan‐Facsinay, A., Jiawan-Lalai, R., Camps, M. G. M., Nouta, J., Melief, C. J. M., Verbeek, J. S., & OSSENDORP, F. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4573 · Cited by 119
Self-citationVambutas, A., DeVoti, J. A., Nouri, M., Drijfhout, J. W., Lipford, G. B., Bonagura, V. R., van der Burg, S. H., & Melief, C. J. M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.049 · Cited by 110
Self-citationIns and Outs of Dendritic Cells
Schuurhuis, D. H., Fu, N., OSSENDORP, F. A., & Melief, C. J. M. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000092002 · Cited by 108
Self-citationAtreya, R. N., & Neurath, M. (2008) · Current Drug Targets · doi:10.2174/138945008784221116 · Cited by 107
Inflammation and cancer: The oncogene-driven connection
Borrello, M. G., Degl’Innocenti, D., & Pierotti, M. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.060 · Cited by 106
del Hoyo, G. M., Martı́n, P., Fernández-Arias, C., Marı́n, A. R., & Ardavı́n, C. (2002) · Blood · doi:10.1182/blood.v99.3.999 · Cited by 105
Hyperthermia Enhances CTL Cross-Priming
Shi, H., Cao, T., Connolly, J. E., Monnet, L., Bennett, L. B., Chapel‐Fernandes, S., Bagnis, C., Mannoni, P., Davoust, J. M., Palucka, A. K., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2134 · Cited by 101
Benítez‐Ribas, D., Adema, G. J., Winkels, G., Klasen, I. S., Punt, C. J. A., Figdor, C. G., & de Vries, I. J. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052364 · Cited by 101
Berg, M., Wingender, G., Djandji, D., Hegenbarth, S. I., Momburg, F., Hämmerling, G. J., Limmer, A., & Knolle, P. A. (2006) · European Journal of Immunology · doi:10.1002/eji.200636033 · Cited by 97
Baruah, P., Propato, A., Dumitriu, I. E., Rovere, P. Q., Russo, V. E. A., Fontana, R., Accapezzato, D., Peri, G., Mantovani, A., Barnaba, V., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1112 · Cited by 97
Combined chemoimmunotherapy of solid tumours: Improving vaccines?
Nowak, A. K., Lake, R., & Robinson, B. W. S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.04.002 · Cited by 94
Processing and presentation of tumor antigens and vaccination strategies
van der Bruggen, P., & den Eynde, B. J. V. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.013 · Cited by 85
Hsp90‐mediated cytosolic refolding of exogenous proteins internalized by dendritic cells
Giodini, A., & Cresswell, P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601941 · Cited by 82
Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells.
van Kester, M., Out-Luiting, J., Borne, P. V. D., Willemze, R., Tensen, C., & Vermeer, M. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701246 · Cited by 82
Shi, X., Franko, B., Frantz, C., Amin, H. M., & Lai, R. L. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06259.x · Cited by 80
Shi, Y., Galusha, S. A., & Rock, K. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3905 · Cited by 80
Welters, M. J. P., van der Logt, P., van den Eeden, S. J. F., Kwappenberg, K. M. C., Drijfhout, J. W., Fleuren, G. J., Kenter, G. G., Melief, C. J. M., van der Burg, S. H., & Offringa, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21459 · Cited by 77
Self-citationLongman, R., Braun, D., Pellegrini, S., Rice, C. M., Darnell, R. B., & Albert, M. L. (2006) · Blood · doi:10.1182/blood-2006-05-023465 · Cited by 71
Gerner, M. Y., Casey, K. A., & Mescher, M. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.155 · Cited by 71
der Most, R. G. V., Currie, A. J., Robinson, B. W. S., & Lake, R. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402255 · Cited by 70
Contradictory functions of NF-κB in liver physiology and cancer
Vainer, G. W., Pikarsky, E., & Ben‐Neriah, Y. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.016 · Cited by 69
Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes
Hargadon, K. M., Brinkman, C. C., Sheasley-O’Neill, S. L., Nichols, L. A., Bullock, T. N. J., & Engelhard, V. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6081 · Cited by 67
Currie, A. J., van der Most, R., Broomfield, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1535 · Cited by 60
Hamzah, J., Nelson, D. J., Moldenhauer, G., Arnold, B., Hämmerling, G. J., & Ganß, R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33201 · Cited by 57
Capitalizing on the Immunogenicity of Dying Tumor Cells
Fonseca, C., & Dranoff, G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2245 · Cited by 56
Cao, T., Ueno, H., Glaser, C., Fay, J. W., Palucka, K., & Banchereau, J. (2007) · European Journal of Immunology · doi:10.1002/eji.200636499 · Cited by 51
Tacken, P. J., Joosten, B., Reddy, A., Wu, D., Eek, A., Laverman, P., Kretz-Rommel, A., Adema, G. J., Torensma, R., & Figdor, C. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7687 · Cited by 44
In Vivo Antigen Stability Affects DNA Vaccine Immunogenicity
Bins, A. D., Wolkers, M. C., van den Boom, M. D., Haanen, J. B. A. G., & Schumacher, T. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2126 · Cited by 43
Dumortier, H., van Mierlo, G. J. D., Egan, D., van Ewijk, W., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.855 · Cited by 39
Self-citationChen, Z., Xia, D., Bi, X., Saxena, A., Sidhu, N., El-Gayed, A. A. H., & Xiang, J. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.692 · Cited by 29
Konda, A., & Duffy, M. C. (2008) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.12.013 · Cited by 23
Maintenance of Immune Tolerance Depends on Normal Tissue Homeostasis
Boonman, Z., van Mierlo, G. V., Fransen, M., de Keizer, R. D., Jager, M., Melief, C., & Toes, R. (2005) · Journal of Immunology · doi:10.4049/jimmunol.175.7.4247 · Cited by 16
Self-citationMOKYR, M. B., Place, A. T., Artwohl, J. E., & Valli, V. ’. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0029-2 · Cited by 14
Cited by
Cross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637
Decisions About Dendritic Cells: Past, Present, and Future
Steinman, R. M. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100311-102839 · Cited by 1,274
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Diamond, M. S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G. P., Archambault, J. M., Lee, H., Arthur, C. D., White, J. M., Kalinke, U., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101158 · Cited by 1,081
Systemic effects of local radiotherapy
Formenti, S. C., & Demaria, S. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70082-8 · Cited by 1,021
Cheong, C., Matos, I., Choi, J.-H., Dandamudi, D. B., Shrestha, E., Longhi, M. P., Jeffrey, K. L., Anthony, R. M., Kluger, C., Nchinda, G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.039 · Cited by 610
Metadata
- Authors
- Melief, C. J. M.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 29
- Issue
- 3
- Pages
- 372-383
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2155412969
- Cited by
- 508
- References
- 148
- FWCI
- 23.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.